Myocardial 'no-reflow' - Diagnosis, pathophysiology and treatment

International Journal of Cardiology

Volumn 167, Issue 5, 2013, Pages 1798-1806

  Wong, Dennis T L ^a   Puri, Rishi ^a   Richardson, James D ^a   Worthley, Matthew I ^a   Worthley, Stephen G ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cardiac MRI; Microvascular dysfunction; Myocardial infarction; No reflow; STEMI; TMPG

Indexed keywords

ABCIXIMAB; ADENOSINE; CARIPORIDE; CYCLOSPORIN; ENDOTHELIN 1; ENIPORIDE; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; NITROPRUSSIDE SODIUM; PEXELIZUMAB; PLACEBO; VERAPAMIL;

ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG MEGADOSE; EMBOLISM; FLOW RATE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; IMAGE ANALYSIS; LOW DRUG DOSE; MICROEMBOLISM; NO REFLOW PHENOMENON; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SINGLE DRUG DOSE; SYNDROME DELINEATION; THROMBOSIS;

CARDIAC MRI; MICROVASCULAR DYSFUNCTION; MYOCARDIAL INFARCTION; NO-REFLOW; STEMI; TMPG;

ANIMALS; ELECTROCARDIOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NO-REFLOW PHENOMENON; TREATMENT OUTCOME;

EID: 84883268343     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.049     Document Type: Review

References (104)

1. R.A. Kloner, C.E. Ganote, and R.B. Jennings The "no-reflow" phenomenon after temporary coronary occlusion in the dog J Clin Invest 54 1974 1496 1508
2. A.W. van 't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, and F. Zijlstra Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group Circulation 97 1998 2302 2306
3. C.M. Gibson, C.P. Cannon, S.A. Murphy, S.J. Marble, H.V. Barron, and E. Braunwald Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction Circulation 105 2002 1909 1913
4. R. Schroder, R. Dissmann, and T. Bruggemann Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction J Am Coll Cardiol 24 1994 384 391
5. M. Kondo, A. Nakano, D. Saito, and Y. Shimono Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction J Am Coll Cardiol 32 1998 898 903
6. H. Ito, A. Okamura, and K. Iwakura Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction Circulation 93 1996 1993 1999
7. K.C. Wu, E.A. Zerhouni, and R.M. Judd Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation 97 1998 765 772
8. D. Brosh, A.R. Assali, and A. Mager Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality Am J Cardiol 99 2007 442 445
9. L. Bolognese, N. Carrabba, and G. Parodi Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction Circulation 109 2004 1121 1126
10. G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea Myocardial no-reflow in humans J Am Coll Cardiol 54 2009 281 292
11. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators N Engl J Med 329 1993 673 682
12. A. Vogt, R. von Essen, U. Tebbe, W. Feuerer, K.F. Appel, and K.L. Neuhaus Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies J Am Coll Cardiol 21 1993 1391 1395
13. L. Karagounis, S.G. Sorensen, R.L. Menlove, F. Moreno, and J.L. Anderson Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction J Am Coll Cardiol 19 1992 1 10
14. C.M. Gibson, C.P. Cannon, and W.L. Daley TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888
15. J.S. Tanedo, R.F. Kelly, and M. Marquez Assessing coronary blood flow dynamics with the TIMI frame count method: comparison with simultaneous intracoronary Doppler and ultrasound Catheter Cardiovasc Interv 53 2001 459 463
16. S. Hamada, T. Nishiue, and S. Nakamura TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction J Am Coll Cardiol 38 2001 666 671
17. C.M. Gibson, S.A. Murphy, and M.J. Rizzo Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group Circulation 99 1999 1945 1950
18. C.M. Gibson, M.I. Dotani, and S.A. Murphy Correlates of coronary blood flow before and after percutaneous coronary intervention and their relationship to angiographic and clinical outcomes in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis Am Heart J 144 2002 130 135
19. C.M. Gibson, Y.B. Pride, and J.L. Buros Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction J Am Coll Cardiol 51 2008 546 551
20. C.M. Gibson, A.J. Kirtane, and D.A. Morrow Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30) Am Heart J 152 2006 756 761
21. E. Appelbaum, J.M. Abraham, and Y.B. Pride Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction Am Heart J 158 2009 84 91
22. A. Araszkiewicz, M. Lesiak, and S. Grajek Effect of microvascular reperfusion on prognosis and left ventricular function in anterior wall myocardial infarction treated with primary angioplasty Int J Cardiol 114 2007 183 187
23. W. Lepper, G.T. Sieswerda, and J.L. Vanoverschelde Predictive value of markers of myocardial reperfusion in acute myocardial infarction for follow-up left ventricular function Am J Cardiol 88 2001 1358 1363
24. R. Nijveldt, A.M. Beek, and A. Hirsch Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury J Am Coll Cardiol 52 2008 181 189
25. J. Vicente, N. Mewton, and P. Croisille Comparison of the angiographic myocardial blush grade with delayed-enhanced cardiac magnetic resonance for the assessment of microvascular obstruction in acute myocardial infarctions Catheter Cardiovasc Interv 74 7 2009 Dec 1 1000 1007
26. P. Sorajja, B.J. Gersh, and C. Costantini Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction Eur Heart J 26 2005 667 674
27. D.T. Wong, M.C. Leung, and R. Das Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size Int J Cardiol 165 1 2013 Apr 30 61 66
28. D.T. Wong, M.C. Leung, and J.D. Richardson Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements Int J Cardiovasc Imaging 28 8 2012 1971 1981 (Dec)
29. P.K. Haager, P. Christott, N. Heussen, W. Lepper, P. Hanrath, and R. Hoffmann Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by markers of myocardial reperfusion J Am Coll Cardiol 41 2003 532 538
30. J.A. de Lemos ST-segment resolution as a marker of epicardial and myocardial reperfusion after thrombolysis: insights from the TIMI 14 and in TIME-II trials J Electrocardiol 33 Suppl. 2000 67 72
31. C.E. Buller, Y. Fu, and K.W. Mahaffey ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial Circulation 118 2008 1335 1346
32. B.G. Angeja, M. Gunda, and S.A. Murphy TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging Circulation 105 2002 282 285
33. A. Poli, R. Fetiveau, and P. Vandoni Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty: real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function Circulation 106 2002 313 318
34. K. Hashimoto, E. Corday, and T.W. Lang Significance of S-T segment elevations in acute myocardial ischemia. Evaluation with intracoronary electrode technique Am J Cardiol 37 1976 493 500
35. P.L. Friedman, T.L. Shook, J.M. Kirshenbaum, A.P. Selwyn, and P. Ganz Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty Circulation 74 1986 330 339
36. T. Uetani, T. Amano, and S. Kumagai Intracoronary electrocardiogram recording with a bare-wire system: perioperative ST-segment elevation in the intracoronary electrocardiogram is associated with myocardial injury after elective coronary stent implantation JACC Cardiovasc Interv 2 2009 127 135
37. V. Balian, M. Galli, and C. Marcassa Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury Circulation 114 2006 1948 1954
38. V. Balian, M. Galli, and S. Repetto Intracoronary ST segment evolution during primary coronary stenting predicts infarct zone recovery Catheter Cardiovasc Interv 64 2005 53 60
39. T. Takahashi, Y. Hiasa, and Y. Ohara Usefulness of coronary flow reserve immediately after primary coronary stenting in predicting wall motion recovery in patients with anterior wall acute myocardial infarction Am J Cardiol 94 2004 1033 1037
40. M. Ishihara, H. Sato, and H. Tateishi Time course of impaired coronary flow reserve after reperfusion in patients with acute myocardial infarction Am J Cardiol 78 1996 1103 1108
41. W.F. Fearon, M. Shah, and M. Ng Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol 51 2008 560 565
42. O.P. Simonetti, R.J. Kim, and D.S. Fieno An improved MR imaging technique for the visualization of myocardial infarction Radiology 218 2001 215 223
43. K.C. Wu, R.J. Kim, and D.A. Bluemke Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion J Am Coll Cardiol 32 1998 1756 1764
44. G.K. Lund, A. Stork, and M. Saeed Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging Radiology 232 2004 49 57
45. S.C. Bekkers, W.H. Backes, and R.J. Kim Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging Eur Radiol 19 12 2009 Dec 2904 2912
46. S. de Waha, S. Desch, and I. Eitel Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers Eur Heart J 31 2010 2660 2668
47. A.N. Mather, T.A. Fairbairn, N.J. Artis, J.P. Greenwood, and S. Plein Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling Radiology 261 2011 116 126
48. L. Galiuto, B. Garramone, and A. Scara The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study J Am Coll Cardiol 51 2008 552 559
49. L. Agati, G. Tonti, and G. Pedrizzetti Clinical application of quantitative analysis in real-time MCE Eur J Echocardiogr 5 Suppl. 2 2004 S17 S23
50. H. Ito, T. Tomooka, and N. Sakai Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction Circulation 85 1992 1699 1705
51. K. Greaves, S.R. Dixon, and M. Fejka Myocardial contrast echocardiography is superior to other known modalities for assessing myocardial reperfusion after acute myocardial infarction Heart 89 2003 139 144
52. A. Skyschally, K. Leineweber, P. Gres, M. Haude, R. Erbel, and G. Heusch Coronary microembolization Basic Res Cardiol 101 2006 373 382
53. H.K. Yip, M.C. Chen, and H.W. Chang Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon Chest 122 2002 1322 1332
54. U. Limbruno, M. De Carlo, and S. Pistolesi Distal embolization during primary angioplasty: histopathologic features and predictability Am Heart J 150 2005 102 108
55. G. De Luca, H. Suryapranata, G.W. Stone, D. Antoniucci, F.J. Neumann, and M. Chiariello Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials Am Heart J 153 2007 343 353
56. H. Kelbaek, C.J. Terkelsen, and S. Helqvist Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial J Am Coll Cardiol 51 2008 899 905
57. T. Svilaas, P.J. Vlaar, and I.C. van der Horst Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 2008 557 567
58. F. Burzotta, C. Trani, and E. Romagnoli Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial J Am Coll Cardiol 46 2005 371 376
59. A.S. Petronio, M. De Carlo, and N. Ciabatti Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine Am Heart J 150 2005 1015
60. Y.L. Gu, M.A. Kampinga, and W.G. Wieringa Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial Circulation 122 2010 2709 2717
61. H. Thiele, K. Schindler, and J. Friedenberger Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial Circulation 118 2008 49 57
62. A. Iversen, U. Abildgaard, and A. Galloe Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial J Interv Cardiol 24 2011 105 111
63. H. Thiele, J. Wohrle, and P. Neuhaus Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial Am Heart J 159 2010 547 554
64. J. Zalewski, A. Undas, J. Godlewski, E. Stepien, and K. Zmudka No-reflow phenomenon after acute myocardial infarction is associated with reduced clot permeability and susceptibility to lysis Arterioscler Thromb Vasc Biol 27 2007 2258 2265
65. D. Atar, P. Petzelbauer, and J. Schwitter Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial J Am Coll Cardiol 53 2009 720 729
66. K.A. Reimer, J.E. Lowe, M.M. Rasmussen, and R.B. Jennings The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs Circulation 56 1977 786 794
67. B.K. Nallamothu, and E.R. Bates Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 92 2003 824 826
68. T. Reffelmann, and R.A. Kloner The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion Basic Res Cardiol 101 2006 359 372
69. J. Tranum-Jensen, M.J. Janse, W.T. Fiolet, W.J. Krieger, C.N. D'Alnoncourt, and D. Durrer Tissue osmolality, cell swelling, and reperfusion in acute regional myocardial ischemia in the isolated porcine heart Circ Res 49 1981 364 381
70. K. Iwakura, H. Ito, and S. Kawano Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction J Am Coll Cardiol 38 2001 472 477
71. M. Francone, C. Bucciarelli-Ducci, and I. Carbone Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 2145 2153
72. J. Zhao, Y. Yang, S. you, C. Cui, and R. Gao Carvedilol preserves endothelial junctions and reduces myocardial no-reflow after acute myocardial infarction and reperfusion Int J Cardiol 115 2007 334 341
73. J.L. Zhao, Y.J. Yang, and S.J. You Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion Coron Artery Dis 17 2006 463 469
74. B.R. Ito, G. Schmid-Schonbein, and R.L. Engler Effects of leukocyte activation on myocardial vascular resistance Blood Cells 16 1990 145 163 [discussion 63-6]
75. T. Takahashi, Y. Hiasa, and Y. Ohara Relation between neutrophil counts on admission, microvascular injury, and left ventricular functional recovery in patients with an anterior wall first acute myocardial infarction treated with primary coronary angioplasty Am J Cardiol 100 2007 35 40
76. H. Matsumoto, N. Inoue, and H. Takaoka Depletion of antioxidants is associated with no-reflow phenomenon in acute myocardial infarction Clin Cardiol 27 2004 466 470
77. G. Niccoli, G.A. Lanza, and S. Shaw Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization Eur Heart J 27 2006 1793 1798
78. L. Galiuto, A.N. DeMaria, and U. del Balzo Ischemia-reperfusion injury at the microvascular level: treatment by endothelin A-selective antagonist and evaluation by myocardial contrast echocardiography Circulation 102 2000 3111 3116
79. A. Skyschally, R. Schulz, and G. Heusch Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning Herz 33 2008 88 100
80. C. Piot, P. Croisille, and P. Staat Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 2008 473 481
81. H.E. Botker, R. Kharbanda, and M.R. Schmidt Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial Lancet 375 2010 727 734
82. P. Theroux, B.R. Chaitman, and N. Danchin Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators Circulation 102 2000 3032 3038
83. M. Marzilli, E. Orsini, P. Marraccini, and R. Testa Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction Circulation 101 2000 2154 2159
84. M.L. Fokkema, P.J. Vlaar, and M. Vogelzang Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial Circ Cardiovasc Interv 2 2009 323 329
85. G. Amit, C. Cafri, and S. Yaroslavtsev Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial Am Heart J 152 887 2006 9 14
86. H. Ishii, S. Ichimiya, and M. Kanashiro Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction Circulation 112 2005 1284 1288
87. P.W. Armstrong, and C.B. Granger Pexelizumab and the APEX AMI trial JAMA 297 2007 1881 [author reply - 2]
88. M.G. Stoel, K.M. Marques, C.C. de Cock, J.G. Bronzwaer, C. von Birgelen, and F. Zijlstra High dose adenosine for suboptimal myocardial reperfusion after primary PCI: a randomized placebo-controlled pilot study Catheter Cardiovasc Interv 71 2008 283 289
89. K.W. Mahaffey, J.A. Puma, and N.A. Barbagelata Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial J Am Coll Cardiol 34 1999 1711 1720
90. A.M. Ross, R.J. Gibbons, G.W. Stone, R.A. Kloner, and R.W. Alexander A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) J Am Coll Cardiol 45 2005 1775 1780
91. V. Pasceri, C. Pristipino, and F. Pelliccia Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction Am J Cardiol 95 2005 1358 1361
92. H. Ito, Y. Taniyama, and K. Iwakura Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction J Am Coll Cardiol 33 1999 654 660
93. H. Ono, T. Osanai, and H. Ishizaka Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation Am Heart J 148 2004 E15
94. M. Kitakaze, M. Asakura, and J. Kim Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials Lancet 370 2007 1483 1493
95. Y. Taniyama, H. Ito, and K. Iwakura Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction J Am Coll Cardiol 30 1997 1193 1199
96. G.S. Werner, K. Lang, H. Kuehnert, and H.R. Figulla Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction Catheter Cardiovasc Interv 57 2002 444 451
97. J.P. Collet, and G. Montalescot The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes Diab Vasc Dis Res 2 2005 136 143
98. P. Golino, P.R. Maroko, and T.E. Carew The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion Circulation 75 1987 292 298
99. K. Malmberg, L. Ryden, and S. Efendic Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year J Am Coll Cardiol 26 1995 57 65
100. K. Iwakura, H. Ito, and S. Kawano Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction Eur Heart J 27 2006 534 539
101. V. Hombach, O. Grebe, and N. Merkle Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging Eur Heart J 26 2005 549 557
102. H. Uyarel, N. Cam, and E. Okmen Level of Selvester QRS score is predictive of ST-segment resolution and 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention Am Heart J 151 1239 2006 e1 e7
103. G. Campo, M. Valgimigli, and D. Gemmati Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study J Am Coll Cardiol 48 2006 2178 2185
104. K. Iwakura, H. Ito, and M. Ikushima Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction J Am Coll Cardiol 41 2003 1 7